Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vittorio Marchesin"'
Autor:
Paul L. Nguyen, Simon Hughes, Andrew J. Martin, Vittorio Marchesin, Howard Chan, Martin R. Stockler, Scott Williams, Sonia Yip, Xanthi Coskinas, Nicola Jane Lawrence, Emily Tu, Wendy Hague, Olwyn Deignan, Christopher Sweeney, Ray McDermott, Ian D. Davis
Publikováno v:
Journal of Clinical Oncology. 34:TPS5086-TPS5086
TPS5086Background: Adjuvant ADT with an LHRH analog (LHRHA) given before during and after radiotherapy (RT) is standard of care for high risk localised prostate cancer (PC). Enzalutamide is more ef...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c98d4ae497d26d3b0c4f14dd1e963c0e
https://doi.org/10.1200/jco.2016.34.15_suppl.tps5086
https://doi.org/10.1200/jco.2016.34.15_suppl.tps5086
Autor:
Emily Tu, Scott A. North, Ray McDermott, Ian D. Davis, Simon Chowdhury, Andrew J. Martin, Alexander Montenegro, Wendy Hague, Francisco E. Vera-Badillo, Martin R. Stockler, Howard Chan, Olwyn Deignan, Vittorio Marchesin, Sonia Yip, Xanthi Coskinas, Nicola Jane Lawrence, Christopher Sweeney
Publikováno v:
Journal of Clinical Oncology. 34:TPS5090-TPS5090
TPS5077 Background: Androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) or surgical castration, either alone or combined with conventional non-steroidal...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5beb983cc396cff4ae7ef861f1e02c67
https://doi.org/10.1200/jco.2016.34.15_suppl.tps5090
https://doi.org/10.1200/jco.2016.34.15_suppl.tps5090
Autor:
Silvia Bojin, Juan C. Jaen, Thomas J. Schall, Vira Tseluyko, Shichang Miao, Paul P. Tak, Pirow Bekker, Andra Balanescu, Vittorio Marchesin, E. Drescher, Dan Dairaghi
Publikováno v:
Annals of the rheumatic diseases, 72(3), 337-344. BMJ Publishing Group
Objectives CCX354-C is a specific, orally administered antagonist of the C-C chemokine receptor 1, which regulates migration of monocytes and macrophages to synovial tissue. This clinical trial evaluated the safety and efficacy of CCX354-C in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482ce74a369d01dd029b5ab1dd26f6ae
https://pubmed.ncbi.nlm.nih.gov/22589376
https://pubmed.ncbi.nlm.nih.gov/22589376
Autor:
Ian D. Davis, Martin R. Stockler, Andrew James Martin, Vittorio Marchesin, Olwyn Deignan, Ray McDermott, Wendy R. Parulekar, Scott A. North, Barbara Graham, Anne Poh Long, Felicia T Roncolato, Sonia Yip, Wendy Hague, Carlo Dazo, Xanthi Coskinas, Christopher Sweeney
Publikováno v:
Journal of Clinical Oncology. 33:TPS5077-TPS5077
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::553ed860a41243ddc00d76b0dac00395
https://doi.org/10.1200/jco.2015.33.15_suppl.tps5077
https://doi.org/10.1200/jco.2015.33.15_suppl.tps5077
Autor:
Vittorio Marchesin, Sonia Yip, Felicia Roncolato, Anne Poh Long, Ian D. Davis, Xanthi Coskinas, Wendy Hague, Scott Williams, Emily Tu, Paul L. Nguyen, Christopher Sweeney, Ray McDermott, Martin R. Stockler, Olwyn Deignan, Andrew J. Martin
Publikováno v:
Journal of Clinical Oncology. 33:TPS5078-TPS5078
TPS5078 Background: Adjuvant androgen deprivation therapy (ADT) including a luteinising hormone releasing hormone analogue (LHRHA) is standard of care given before, during, and after radiotherapy f...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46668ed20d0ce81bd6a549e9a5db673b
https://doi.org/10.1200/jco.2015.33.15_suppl.tps5078
https://doi.org/10.1200/jco.2015.33.15_suppl.tps5078